参考文献/References:
[1] 尤徐阳, 贺锋, 徐巧玲,等. 18F-FDG PET/CT同机序贯增强CT在胃癌治疗前分期中的价值[J]. 中华核医学与分子影像杂志, 2016, 36(4):315-321. DOI:10.3760/cma.j.issn.2095-2848. 2016. 04.009. You XY, He F, Xu QL, et al. Sequential 18F-FDG PET/CT and contrast-enhanced CT in the pretreatment staging of gastric cancer[J]. Chin J Nucl Med Mol Imaging, 2016, 36(4):315-321.
[2] Xu H, Guo R, Xu W, et al. 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan after gastric endoscopy in those who present with non-specific symptoms, is it necessary or not?[J]. South Asian J Cancer, 2017, 6(2):59-63. DOI:10.4103/2278-330X.208853.
[3] 陈凛, 卢灿荣. 新版日本胃癌"处理规约"和"治疗指南"之解读[J]. 临床外科杂志, 2012, 20(1):10-14. DOI:10.3969/j.issn.1005-6483.2012.01.005. Chen B, Lu CR. Interpretation of the new version of gastric cancer in Japan "Processing protoco" and "treatment guidelines"[J]. J Clin Surg, 2012, 20(1):10-14.
[4] 金民山, 张俊, 姜一逸, 等. 18F-FDG PET/CT在不明原发灶肿瘤中的临床应用价值[J]. 国际放射医学核医学杂志, 2017, 41(2):94-97, 149. DOI:10.3760/cma.j.issn.1673-4114.2017.02.003. Jin MS, Zhang J, Jiang YY, et al. Clinical value of 18F-FDG PET/CT in cancer of unknown primary[J]. Int J Radiat Med Nucl Med, 2017, 41(2):94-97,149.
[5] Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas:correlation with endoscopic and histopathological findings[J]. Eur J Nucl Med Mol Imaging, 2003, 30(2):288-295. DOI:10.1007/s00259-002-1029-5.
[6] Chen R, Zhou X, Liu J, et al. Relationship between 18F-FDG PET/CT findings and HER2 expression in gastric cancer[J]. J Nucl Med, 2016, 57(7):1040-1044. DOI:10.2967/jnumed.115.171165.
[7] Tian J, Chen L, Wei B, et al. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies[J]. Nucl Med Commun, 2004, 25(8):825-831. DOI:10.1097/01.mnm.0000135042.54461.f6.
[8] Mochiki E, Kuwano H, Katoh H, et al. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer[J]. World J Surg, 2004, 28(3):247-253. DOI:10.1007/s00268-003-7191-5.
[9] Fonocho E, Aydin N, Reddy S, et al. Limitations in the use of 18F-FDG PET in the pre-operative staging of gastric cancer:A case series[J]. Int J Surg Case Rep, 2017, 36:147-150. DOI:10.1016/j.ijscr.2017. 05.026.
[10] Yamada A, Oguchi K, Fukushima M, et al. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma:relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression[J]. Ann Nucl Med, 2006, 20(9):597-604.
[11] Dassen AE, Lips DJ, Hoekstra CJ, et al. FDG-PET has no definite role in preoperative imaging in gastric cancer[J]. Eur J Surg Oncol, 2009, 35(5):449-455. DOI:10.1016/j.ejso.2008.11.010.
[12] Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013:featured updates to the NCCN Guidelines[J]. J Natl Compr Canc Netw, 2013, 11(5):531-546. DOI:10.6004/jnccn.2013.0070.
[13] Ozkan E, Araz M, Soydal C, et al. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastric cancer:comparison with spiral CT[J]. World J Surg Oncol, 2011, 9:75. DOI:10.1186/1477-7819-9-75.
[14] Shin JA, Park JW, An M, et al. Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma[J]. Korean J Hepatol, 2006, 12(4):546-552.
[15] Imamura H, Kurokawa Y, Kawada J, et al. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer:results of a randomized controlled trial[J]. World J Surg, 2011, 35(3):625-630. DOI:10.1007/s00268-010-0914-5.
[16] Fujita J, Kurokawa Y, Sugimoto T, et al. Survival benefit of bursectomy in patients with resectable gastric cancer:interim analysis results of a randomized controlled trial[J]. Gastric Cancer, 2012, 15(1):42-48. DOI:10.1007/s10120-011-0058-9.
[17] Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:the MUNICON phase Ⅱ trial[J]. Lancet Oncol, 2007, 8(9):797-805. DOI:10.1016/S1470-2045(07)70244-9.
相似文献/References:
[1]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[4]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[5]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[6]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[7]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[8]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[9]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[10]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[11]李生栩,唐明灯,林端瑜,等.18F-FDG SPECT-CT诊断胃癌术后复发及转移的价值[J].国际放射医学核医学杂志,2011,35(5):269.[doi:10.3760/cma.j.issn.1673-4114.2011.05.004]
LI Sheng-xu,TANG Ming-deng,LIN Duan-yu,et al.The value of 18F-FDG SPECT-CT in detecting recurrence and metastasis of gastric carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):269.[doi:10.3760/cma.j.issn.1673-4114.2011.05.004]
[12]梁琰,杜娟,李展展,等.18F-FDG SPECT/CT显像与64排螺旋CT异机融合技术在胃癌诊断中的应用[J].国际放射医学核医学杂志,2017,41(6):385.[doi:10.3760/cma.j.issn.1673-4114.2017.06.002]
Liang Yan,Du Juan,Li Zhanzhan,et al.Benefits of using 18F-FDG SPECT/CT combined with the 64-multislice spiral CT in gastric cancer diagnosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):385.[doi:10.3760/cma.j.issn.1673-4114.2017.06.002]
[13]徐鑫,邓胜明,李继会,等.18F-FDG PET/CT在胃癌分期、复发检测及预后评估中的应用价值[J].国际放射医学核医学杂志,2018,(6):541.[doi:10.3760/cma.j.issn.1673-4114.2018.06.012]
Xu Xin,Deng Shengming,Li Jihui,et al.Progress in research on the use of 18F-FDG PET/CT in the staging, recurrence detection, and prognosis evaluation of patients with gastric carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):541.[doi:10.3760/cma.j.issn.1673-4114.2018.06.012]